Monday, April 27, 2009

Sponsored by the Damon Runyon Cancer Research Foundation and the New York Academy of Sciences

This one-day symposium commemorated the 10th year of the Damon Runyon Clinical Investigator Award.  The event featured distinguished awardees and alumni of the program, who spoke about their groundbreaking discoveries in the area of translational cancer research.  In addition, the schedule included Keynote speaker Robert A. Weinberg, PhD.  The day culminated with a panel discussion entitled “Moving from Discovery through Development – The Evolving Relationship between Academia and Industry.”

Download the Damon Runyon Clinical Investigator Symposium program and speakers' abstracts.

Damon Runyon Clinical Investigator Speakers: Joseph A. Califano, III, MD ('01-'06), The Johns Hopkins University School of Medicine Madhav Dhodapkar, MD ('02-'07), Yale University School of Medicine Maura L. Gillison, MD, PhD ('00-'05), The Johns Hopkins University School of Medicine William M. Grady, MD ('02-'07), Fred Hutchinson Cancer Research Center Pierre P. Massion, MD ('03-'08), Vanderbilt University Medical Center Jeremy N. Rich, MD ('04-'09), Duke University Medical Center Cassian Yee, MD ('01-'06), Fred Hutchinson Cancer Research Center
Panel Discussion Participants: Jakob Dupont, MD ('04-'06), Damon Runyon-Lilly Clinical Investigator Medical Director, Exploratory Clinical Development, BioOncology, Genentech Inc. Richard B. Gaynor, MD, Damon Runyon Board Member Vice President, Cancer Research and Global Oncology Platform, Eli Lilly and Company John Mendelsohn, MD ('72-'74), Damon Runyon Grantee President, The University of Texas M.D. Anderson Cancer Center Donald W. Rucker, MD Vice President and Chief Medical Officer, Siemens Medical Solutions USA Charles L. Sawyers, MD, Former Damon Runyon Clinical Investigator Mentor HHMI Investigator, Chairman of Human Oncology and Pathogenesis Program (HOPP) at Memorial Sloan-Kettering Cancer Center
Scientific Organizing Committee: Richard J. O'Reilly, MD, (Chair of Clinical Investigator Award Committee), Memorial Sloan-Kettering Cancer Center Frederick R. Appelbaum, MD, Fred Hutchinson Cancer Research Center Bruce A. Chabner, MD, Massachusetts General Hospital Patricia A. Ganz, MD, University of California, Los Angeles Richard B. Gaynor, MD, Eli Lilly and Company Hedvig Hricak, MD, PhD, Memorial Sloan-Kettering Cancer Center William G. Kaelin, Jr., MD, Dana-Farber Cancer Institute David M. Livingston, MD, Dana-Farber Cancer Institute